GOLDMAN SACHS GROUP INC - BIND THERAPEUTICS INC ownership

BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 39 filers reported holding BIND THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BIND THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$11,000
-85.9%
28,921
+104.1%
0.00%
Q1 2015$78,000
+9.9%
14,170
+8.1%
0.00%
Q4 2014$71,00013,1050.00%
Other shareholders
BIND THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 2,018,253$10,899,0008.62%
Rhenman & Partners Asset Management AB 133,535$721,0000.21%
AlpInvest Partners B.V. 15,258$82,0000.20%
Spark Investment Management LLC 55,900$300,0000.05%
TFS CAPITAL LLC 29,208$158,0000.02%
PRELUDE CAPITAL MANAGEMENT, LLC 16,000$86,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 63,700$344,0000.01%
THOMPSON DAVIS & CO., INC. 1,000$5,0000.01%
PRINCIPAL FINANCIAL GROUP INC 302,165$1,632,0000.00%
ARROWGRASS CAPITAL PARTNERS (US) LP 22,500$122,0000.00%
View complete list of BIND THERAPEUTICS INC shareholders